Exact Sciences to Participate in May Investor Conference

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • BofA Securities Health Care Conference, Las Vegas

    Fireside chat on Wednesday, May 14, 2025 at 1:40 p.m. ET (10:40 a.m. PT)

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.38
+2.44 (1.12%)
AAPL  259.98
+1.53 (0.59%)
AMD  235.01
+4.78 (2.08%)
BAC  51.68
+0.58 (1.13%)
GOOG  255.06
+2.53 (1.00%)
META  735.07
+1.66 (0.23%)
MSFT  523.16
+2.62 (0.50%)
NVDA  182.59
+2.31 (1.28%)
ORCL  282.25
+9.59 (3.52%)
TSLA  444.86
+5.89 (1.34%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.